Intralesional Steroid Injection Versus Voice Therapy in Management of Vocal Nodules

Launched by ASSIUT UNIVERSITY · Apr 11, 2019

Keywords

ClinConnect Summary

This clinical trial is looking at two different treatments for vocal nodules in adult women, which are small growths on the vocal cords that can cause voice problems. The study is comparing intralesional steroid injections, which are shots given directly into the nodules to help reduce inflammation, with voice therapy using the Accent method, a specialized technique that helps improve voice quality. The goal is to find out which treatment is more effective for helping women who struggle with voice issues due to vocal nodules.

To be eligible for this trial, participants must be women between the ages of 18 and 55 who have been diagnosed with specific types of vocal nodules. They should have normal speaking and hearing abilities and must not have had previous voice therapy or surgery for their condition. Participants can expect to receive one of the two treatments and will be monitored throughout the trial to see how well they respond. This study is currently recruiting, so if you or someone you know fits the criteria and is interested, it could be a good opportunity to help improve management of vocal nodules.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • - 1- Female patients diagnosed with bilateral vocal fold soft edematous nodules with preserved stroboscopic waves , don't exceed base 2.5 mm and apex .5mm.
• • 2- age: 18-55 years. 3- Normal articulation, resonance and language ability. 4- Normal hearing.
• Exclusion Criteria:
• • 1- Previous voice therapy or micro-phono-surgery. 2- Use of drugs (which may cause changes in laryngeal function, mucosa, or muscle activity).
• • 3- History of allergies, lung disease, gastroesophageal reflux disease, or other concomitant vocal pathology (e.g., vocal polyp and vocal cyst).
• • 4- Current psychiatric, neurological conditions.